| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.6B | $19.9B | $17.9B | $16.2B | $3.5B | $10.9B | $3.1B | $2.9B |
| Cost of Revenue | $18.9B | $16.7B | $14.9B | $13.3B | $11.0B | $9.1B | $10.2B | $9.9B |
| Gross Profit | $3.6B | $3.2B | $3.0B | $3.0B | $0.7B | $1.8B | $0.5B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.5B | $2.2B | $1.9B | $1.8B | $1.5B | $1.2B | $1.4B | $1.3B |
| Operating Income | $0.7B | $0.9B | $1.0B | $1.1B | $0.9B | $0.5B | $0.1B | $0.3B |
| Net Income | $0.3B | $0.5B | $0.6B | $0.8B | $0.1B | $0.3B | $0.0B | $0.0B |
| EPS (Basic) | $25.29 | $36.96 | $42.89 | $47.29 | $4.85 | $15.55 | $2.57 | $1.62 |
| EPS (Diluted) | $25.24 | $36.81 | $42.73 | $47.14 | $4.84 | $15.51 | $2.57 | $1.62 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.3B | $9.8B | $7.8B | $6.7B | $5.7B | $5.1B | $5.6B | $5.0B |
| Current Assets | $3.7B | $3.5B | $2.8B | $2.0B | $1.7B | $2.0B | $2.5B | $2.4B |
| Cash & Equivalents | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.4B | $3.4B | $2.5B | $1.9B | $1.5B | $1.8B | $2.4B | $2.4B |
| Stockholders' Equity | $2.8B | $3.0B | $2.7B | $2.2B | $1.8B | $1.4B | $1.3B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.2B | $0.6B | $1.3B | $0.8B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.7B | $-1.3B | $-0.4B | $-0.5B | $-1.3B | $-0.1B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.0B | $0.7B | $0.2B | $-0.1B | $-0.1B | $-0.7B | $-0.1B | $-0.1B |